Celon Pharma (FRA:8RP) FFO


FRA:8RP Celon Pharma SA FRA:8RP
48 GF Score
Price €4.39
GF Value €5.11
! 3 Warning Signs
View Full Analysis

What is Celon Pharma FFO?

FFO (Funds from operations) only applies to REITs.

FRA:8RP
48GF Score
Celon Pharma SA FRA:8RP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Celon Pharma (FRA:8RP) Overvalued in 2026?

Based on GuruFocus' analysis, Celon Pharma stock appears to be undervalued. The current stock price of €4.39 is trading 14.1% below its estimated GF Value™ of €5.11.

Key valuation signals for FRA:8RP:

  • FFO:
  • GF Value™: €5.11 vs. price of €4.39 (14.1% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the FRA:8RP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Celon Pharma Business Description

Other Exchanges CLN:Poland
Address Ogrodowa 2A, Kielpin, Lomianki, POL, 05-092
Celon Pharma SA is a Poland based company engages in the research of therapeutic solutions and development, production, distribution, and marketing of specialized generic products. It invests in the development of innovative pharmaceuticals with potential applications in the treatment of cancer, neurological diseases, diabetes and other metabolic disorders. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir, and Valzek, as well as inhalation powder.
48GF Score

Get the complete analysis for FRA:8RP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.39
Price
€5.11
GF Value